Myeloma Paper of the Day, April 22nd, suggested by Robert Orlowski – OncoDaily
Myeloma Paper of the Day, April 22nd, suggested by Robert Orlowski / BRAF mutations, cancer, KRAS mutation, MD Anderson Cancer Cente, monoclonal plasma cell
Myeloma Paper of the Day, April 22nd, suggested by Robert Orlowski / BRAF mutations, cancer, KRAS mutation, MD Anderson Cancer Cente, monoclonal plasma cell
A highly pathogenic avian influenza A(H5N1) virus infection was identified in a dairy farm worker in Texas. This pathogen has been reported in multiple dairy…
Lara C. Pullen, PhD, is a freelance medical writer in Chicago, Illinois. New research supports the incorporation of white blood cell (WBC) count into polycythemia…
Cancer Medicine is an open access, broad-scope oncology journal covering clinical cancer research, cancer biology, cancer prevention, & bioinformatics.
Program now available for the 12th International Conference on Thrombosis and Hemostasis Issues in Cancer (ICTHIC), Bergamo, Italy, May 17-19, 2024.Visit www.icthic.com to know more!
We aimed to demonstrate the clinical feasibility and safety of simulation-free hippocampal avoidance whole brain radiation therapy (HA-WBRT) in a pilot study (NCTXXX).
CA: A Cancer Journal for Clinicians is ACS’ flagship clinical oncology journal publishing information about the prevention, early detection, and treatment of cancer.
PURPOSE This review summarizes the published evidence on the clinical impact of using next-generation sequencing (NGS) tests to guide management of patients with cancer in…
Stay ahead in precision medicine with the 2nd Biennial Miami Precision Medicine conference. Join healthcare professionals for cutting-edge CME events, featuring expert insights, innovative strategies,…
Sarah Belcher, Susan Sereika, Jacqueline Dunbar-Jacob, Katherine Yeager, Margaret Rosenzweig, Mounzer Agha, Benyam Muluneh, Lindsay Sabik, Valire Copeland, Sarah McGregor, Catherine Bender University of Pittsburgh,…
Tyrosine kinase inhibitors and immune checkpoint inhibitors (ICIs), each requiring testing for precision biomarkers, have recently been approved in the adjuvant setting. We assessed the…